Clinical Trials Logo

Nystagmus, Congenital clinical trials

View clinical trials related to Nystagmus, Congenital.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00799942 Terminated - Multiple Sclerosis Clinical Trials

Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus

Start date: May 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the long-term safety, tolerability and efficacy of neramexane mesylate in the treatment of congenital idiopathic nystagmus (CIN). In addition, a subgroup of multiple sclerosis (MS) patients suffering from acquired nystagmus will be included.